TXG 10-Q: SEC filing
10x Genomics
Filed with the SEC on · accession 0001628280-26-071199
TXG filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
10x Genomics filed its quarterly 10-Q report for the period ending September 30, 2026, confirming its status as a large accelerated filer with Class A and Class B common stock outstanding.
Key details
✦ Ask GOAX AI about this filing — what it means for TXG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TXG?
Click hereFrequently asked questions
What did TXG file with the SEC on Nov 6, 2026?
TXG filed a 10-Q (SEC filing). 10x Genomics filed its quarterly 10-Q report for the period ending September 30, 2026, confirming its status as a large accelerated filer with Class A and Class B common stock outstanding.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other TXG SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · SEC filingNov 2, 2026
- 10-Q · SEC filingAug 7, 2026
- 8-K · SEC filingAug 6, 2026
- 144 · SEC filingJun 16, 2026
- 8-K · SEC filingJun 8, 2026
- 144 · Insider sale plannedMay 26, 2026
- 144 · Insider sale plannedMay 22, 2026
- 144 · SEC filingMay 22, 2026
- 144 · Insider sale plannedMay 22, 2026
Get alerts when TXG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days